Posted by & filed under Company Analysis, Financial analysis, Governments & Regulators, Growth & Valuation, Industry Analysis, Management Issues.

Description: The CEO of Novartis sits down with Fortune’s Susie Gharib and talks about how M&A’s help companies to develop innovative drugs faster.


Date: May 06, 2015


Questions for Discussions:

  • Why is there more M&A interest in the pharmaceutical industry?
  • Is this a good thing for the industry?
  • How should investors approach this industry?

Leave a Reply

Your email address will not be published. Required fields are marked *